Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
3-5 November 2026
RAIAmsterdam, Netherlands

Federico Di Chiaro
Senior CMC Project Manager at Zealand Pharma
Speaker

Profile

Federico Di Chiaro is an experienced CMC leader with over five years of expertise driving CMC programs across both biotech and global pharmaceutical organizations. At Zealand Pharma, he leads cross-functional CMC teams with responsibility for CMC strategy, governance, risk management, execution, and budget oversight, while serving as the CMC representative on global project teams.

Prior to Zealand Pharma, Federico held roles at Novo Nordisk, building extensive experience in drug substance and API development, GMP operations, CDMO management, and cross-functional stakeholder engagement.

Passionate about strengthening CMC capabilities, Federico is focused on accelerating development timelines, supporting portfolio growth, and delivering long-term value across innovative drug development programs.

Agenda Sessions

  • Dapiglutide: From Lab to Large Scale Manufacture through Innovative Peptide Process Development

    16:15